CME Listings
New Kids on the Block: Antimicrobial Advances in the Management of Gram-Positive Skin Infections
IDCareLive
1.5
AMA PRA Category 1
Live Course; Enduring Material
Free
November 4, 2015 00:00
5/4/2016
Course Highlights:
- Examine reduced efficacy of vancomycin on MRSA
- Consider changing bacterial epidemiology of acute bacterial skin infections
- Explore clinical efficacy of oritavancin, dalbavancin, and tedizolid in treating skin infections
- Review new antimicrobial drugs with efficacy against MRSA